Platelet aggregation is a crucial physiological process that plays a central role in hemostasis, the prevention of excessive bleeding, and wound healing. Platelets, small cell fragments in the blood, adhere to exposed collagen at the site of vascular injury. Upon activation, platelets release chemical signals that further attract and activate additional platelets. This cascade of events leads to the formation of a plug, or clot, effectively sealing the breach in the blood vessel. While platelet aggregation is essential for maintaining vascular integrity, dysregulation of this process can contribute to pathological conditions, such as thrombosis or excessive clotting. Understanding the mechanisms behind platelet aggregation is fundamental not only for unraveling the complexities of hemostasis but also for developing therapeutic strategies to manage cardiovascular diseases and related disorders.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain